Bionano Genomics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-2.6% -$212K
$8M
Cost of Revenue↓-4.1% -$194K
$5M
R&D↓-7.1% -$245K
$3M
SG&A↓-25.9% -$3M
$9M
D&A↓-2.5% -$61K
$2M
Operating Income↑+80.6% +$35M
$-9M
EBITDA↓-2.5% -$61K
$2M
Interest Expense↑+22.7% +$51K
$276K
Interest Income↓-62.5% -$500K
$300K
Other Income/Expense↑+476.4% +$262K
$317K
Pretax Income↑+80.8% +$36M
$-8M
Tax Provision↑+3400.0% +$34K
$35K
Net Income↑+80.8% +$36M
$-9M
Operating Margin↑+607.0pts
-115.9%
Net Margin↑+613.1pts
-115.4%
Effective Tax Rate↓-0.1pts
-0.2%
ETR (Continuing Operations)↓-0.2pts
-0.3%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.3pts
-0.7%
ETR Foreign Differential (pp)↓-0.2pts
-0.1%
Operating Lease Cost↓-55.6% -$1M
$1M
Revenue YoY Variation↑+21.3pts
-2.6%
Income YoY Variation↑+19.3pts
80.6%
Revenue QoQ Variation↓-26.5pts
7.9%
Income QoQ Variation↑+148.5pts
-9.5%